coval
posttransl
modif
protein
ubiquitin
ubiquitinlik
factor
emerg
gener
mechan
regul
myriad
intracellular
process
addit
remov
ubiquitin
ubiquitinlik
protein
factor
recent
demonstr
key
mechan
modul
dna
damag
respons
ddr
pathway
thu
time
evalu
potenti
ubiquitin
pathway
enzym
ddr
drug
target
therapeut
intervent
synthet
lethal
approach
provid
excit
opportun
develop
target
therapi
treat
cancer
tumour
lost
critic
ddr
pathway
thu
reli
heavili
remain
pathway
normal
tissu
still
equip
ddr
pathway
review
key
deubiquityl
enzym
dub
involv
ddr
pathway
describ
target
dub
may
lead
select
therapi
treat
cancer
patient
keyword
synthet
lethal
ubiquitin
deubiquityl
enzym
dub
dna
damag
respons
dna
repair
drug
discoveri
checkpoint
control
abbrevi
ber
base
excis
repair
cpd
cyclobutan
pyridin
dimer
ddr
dna
damag
respons
dsb
dna
doublestrand
break
fa
fanconi
anaemia
h
hydrogen
peroxid
hr
homolog
recombin
hu
hydroxyurea
ir
ionis
radiat
mmc
mitomycin
c
ner
nucleotid
excis
repair
nhej
nonhomolog
endjoin
tl
transles
synthesi
uv
ultraviolet
light
tumorigenesi
multistep
process
driven
genet
alter
allow
progress
transform
normal
cell
highli
malign
tumour
genom
instabl
fuell
dna
damag
error
introduc
dna
replic
mani
factorswhich
includ
endogen
aris
agent
reactiv
oxygen
speci
metabol
byproduct
togeth
exogen
agent
ultraviolet
light
ionis
radiat
tobacco
smoke
chemic
genotox
chemicalshav
identifi
gener
rang
differ
damag
type
lesion
dna
see
recent
review
sever
complex
interconnect
dnarepair
system
therefor
evolv
recognis
correct
insult
inflict
cell
vital
genet
inform
importantli
radiotherapi
commonlyus
anticanc
chemotherapi
oper
gener
dna
damag
effect
tumour
erad
treatment
result
gener
irrepar
dna
abstract
coval
posttransl
modif
protein
ubiquitin
ubiquitinlik
factor
emerg
gener
mechan
regul
myriad
intracellular
process
addit
remov
ubiquitin
ubiquitinlik
protein
factor
recent
demonstr
key
mechan
modul
dna
damag
respons
ddr
pathway
thu
time
evalu
potenti
ubiquitin
pathway
enzym
ddr
drug
target
therapeut
intervent
synthet
lethal
approach
provid
excit
opportun
develop
target
therapi
treat
cancer
tumour
lost
critic
ddr
pathway
thu
reli
heavili
remain
pathway
normal
tissu
still
equip
ddr
pathway
review
key
deubiquityl
enzym
dub
involv
ddr
pathway
describ
target
dub
may
lead
select
therapi
treat
cancer
patient
tumorigenesi
multistep
process
driven
genet
alter
allow
progress
transform
normal
cell
highli
malign
tumour
genom
instabl
fuell
dna
damag
error
introduc
dna
replic
mani
factorswhich
includ
endogen
aris
agent
reactiv
oxygen
speci
metabol
byproduct
togeth
exogen
agent
ultraviolet
light
ionis
radiat
tobacco
smoke
chemic
genotox
chemicalshav
identifi
gener
rang
differ
damag
type
lesion
dna
see
recent
review
sever
complex
interconnect
dnarepair
system
therefor
evolv
recognis
correct
insult
inflict
cell
vital
genet
inform
importantli
radiotherapi
commonlyus
anticanc
chemotherapi
oper
gener
dna
damag
effect
tumour
erad
treatment
result
gener
irrepar
dna
damag
tumour
cell
resist
mechan
provid
tumour
cell
dnarepair
pathway
dna
damag
normal
cell
result
toxic
usual
associ
treatment
overlap
dna
repair
pathway
oper
mammalian
cell
togeth
dnadamag
signal
process
compris
often
refer
cellular
dna
damag
respons
ddr
defect
caus
variou
human
diseas
prime
aspect
ddr
variou
dna
repair
mechan
encompass
nucleotid
excis
repair
ner
base
excis
repair
ber
pathway
deal
variou
dna
helixdistort
lesion
singlestrand
break
mismatch
repair
pathway
deal
base
mismatch
insertionsdelet
toxic
dna
doublestrand
break
dsb
either
dealt
nonhomolog
endjoin
pathway
nhej
andor
less
errorpron
homolog
recombin
hr
pathway
addit
fanconi
anaemia
fa
pathway
oper
conjunct
certain
hr
factor
recognis
repair
lesion
interstrand
dna
crosslink
cellular
respons
dna
damag
propag
signal
transduct
posttransl
modif
protein
involv
variou
dna
repair
pathway
amplif
signal
damag
site
import
regulatori
function
control
cell
respons
dna
lesion
respons
damag
take
sever
form
depend
cell
cell
cycl
replic
statu
level
damag
incur
instanc
signal
trigger
cellcycl
checkpoint
caus
cell
slow
stop
cellcycl
progress
therebi
prevent
replic
damag
dna
templat
mitot
segreg
damag
chromosom
howev
level
damag
high
incompat
repair
ddr
signal
may
trigger
apoptot
cell
death
autophagi
senesc
mechan
either
cell
kill
place
nondivid
phenotyp
central
mani
respons
follow
dna
damag
regul
modif
chromatin
mediat
variou
posttransl
process
import
trigger
variou
ddr
event
maintain
genom
integr
although
ddr
defici
link
wide
rang
human
patholog
infertil
immunesystem
defect
neurolog
defect
development
disord
research
focus
strike
associ
exist
ddr
defect
cancer
inde
hereditari
mutat
epigenet
silenc
varieti
gene
control
dna
repair
process
recognis
caus
contribut
earli
cancer
format
mani
instanc
exampl
mutat
dna
mismatch
repair
gene
lead
nonpolyposi
colorect
cancer
hnpcc
signific
number
patient
similarli
defect
hrpromot
ddrsignal
protein
kinas
atm
characteris
syndrom
ataxia
telangiectasia
associ
increas
incid
malign
furthermor
mutat
dna
repair
gene
blm
wrn
give
rise
syndrom
associ
highcanc
preval
inherit
mutat
strongli
breast
cancer
predispos
gene
involv
hr
dsb
repair
process
respons
consider
proport
famili
breast
ovarian
cancer
case
mutat
carrier
also
show
increas
risk
develop
cancer
type
includ
prostat
pancreat
stomach
cancer
fa
anoth
diseas
mutat
one
fifteen
fa
gene
lead
defect
dna
interstrand
crosslink
icl
repair
hr
associ
increas
cancer
incid
addit
ddr
factor
link
cancer
hereditari
connect
strong
grow
evid
ddr
defect
contribut
wide
sporad
cancer
inde
one
frequent
earli
event
tumorigenesi
involv
abrog
particular
ddr
process
one
aspect
ddr
dysfunct
result
increas
genom
instabl
consequ
increas
mutat
rate
turn
foster
cancer
initi
progress
addit
loss
certain
ddr
compon
appear
select
earli
stage
tumorigenesi
dampen
genotox
stressinduc
cell
death
pathway
would
otherwis
trigger
heighten
level
dna
damag
induct
exist
mani
cancer
precursor
part
higher
dnadamag
load
cancer
aris
factor
telomer
shorteningwhich
trigger
ddr
activ
growth
nonoptim
environ
moreov
recent
studi
shown
activ
variou
oncogen
ra
myc
lead
replic
stress
thu
lead
dna
damag
sphase
light
factor
cancer
cell
invari
display
differ
ddr
repertoir
normal
cell
patient
crucial
often
mean
cancer
cell
reliant
certain
ddr
pathway
normal
cell
addict
relianc
particular
repair
pathway
exploit
therapeut
cancer
concept
synthet
lethal
scenario
drug
inhibit
particular
ddr
compon
much
toxic
cancer
cell
normal
cell
fig
instanc
ddr
target
drug
enhanc
cytotox
standard
radiotherapi
chemotherapi
much
cancer
cell
normal
cell
variou
potenti
avenu
drug
ddr
pathway
studi
date
focus
target
enzym
control
dna
repair
mediat
posttransl
modif
modif
oper
mani
way
ddr
often
regul
assembl
disassembl
ddrprotein
complex
well
control
localis
andor
intrins
activ
ddr
compon
inde
sever
compound
oper
way
block
ddr
protein
phosphoryl
polyadpribosyl
gener
produc
encourag
result
clinic
trial
discuss
previous
recent
becom
evid
ubiquityl
well
revers
process
deubiquityl
play
key
role
ddr
associ
downstream
process
consequ
enzym
control
ubiquityl
relat
process
offer
variou
new
opportun
therapeut
intervent
ubiquitin
residu
polypeptid
use
posttransl
modif
alter
intracellular
protein
function
histor
ubiquityl
system
identifi
atpdepend
signal
target
intracellular
protein
proteasom
degrad
ubiquityl
protein
multistep
process
requir
sequenti
action
three
enzym
ubiquitinactiv
enzym
activ
ubiquitin
subsequ
load
onto
ubiquitinconjug
enzym
final
ubiquitin
coval
link
lysin
sidechain
via
specif
recruit
target
protein
facilit
transfer
ubiquitin
ligas
notabl
addit
ubiquitin
sometim
link
target
protein
singli
form
monoubiquitin
adduct
mani
case
initi
ubiquitin
attach
extend
coval
attach
protein
addit
ubiquitin
moieti
form
polyubiquitin
chain
moreov
one
ubiquitin
seven
intern
lysin
residu
amino
terminu
serv
site
conjug
result
polyubiquitin
chain
variou
highli
distinct
topolog
differ
biochem
biolog
function
link
polyubiquityl
protein
wide
recognis
critic
pathway
protein
degrad
mani
addit
role
attribut
either
polyubiquityl
protein
via
chain
linear
ubiquitin
chain
well
monoubiquityl
protein
addit
posttransl
modif
ubiquitin
whole
famili
ubiquitinlik
modif
describ
degre
conserv
ubiquitin
ubiquitinlik
factor
somewhat
limit
protein
sequenc
level
howev
member
famili
share
similar
overal
threedimension
structur
highli
relat
mechan
conjug
respect
target
involv
enzym
protein
posttransl
modif
conjug
ubiquitin
ubiquitinlik
factor
target
protein
revers
mediat
isopeptidas
enzym
often
collect
refer
deubiquityl
enzym
dub
dub
compris
larg
class
intracellular
peptidas
cleav
ubiquitin
polypeptid
substrat
substrat
ubiquitin
precursor
ubiquitin
adduct
polyubiquitin
chain
monoubiquityl
protein
polymonoubiquityl
protein
fig
synthet
lethal
relationship
process
loss
ddr
pathway
tumorigenesi
depict
summaris
critic
differ
normal
tumour
cell
cancer
part
driven
chang
cell
dna
repair
capac
ddr
inhibit
pathway
select
kill
cancer
cell
process
call
synthet
lethal
cell
biochem
biophi
includ
ubiquitinlik
peptidas
calcul
hundr
dub
encod
human
genom
dub
classifi
five
famili
fig
ubiquitin
carboxyltermin
hydrolas
uch
ubiquitinspecif
proteas
usp
ovarian
tumour
proteas
otu
mjd
josephin
mpn
jamm
metalloenzym
first
four
famili
cystein
peptidas
mpn
jamm
metallopeptidas
addit
process
ubiquitin
ubiquitin
adduct
usp
shown
select
process
specif
ubiquitinlik
protein
exampl
act
ubiquitinlik
protein
case
sumo
famili
ubiquitinlik
protein
howev
adduct
revers
specialis
group
dub
term
senp
cystein
peptidas
dub
peptidas
consider
differ
precis
mechan
action
also
major
differ
regulatori
mechan
modul
dub
select
specif
regard
dub
classifi
three
main
categori
accord
type
substrat
cleavag
activ
gener
free
ubiquitin
linear
substrat
polyubiquitin
chain
ribosom
protein
fusion
other
liber
ubiquitin
protein
modifi
posttransn
lysin
residu
third
class
compris
dub
edit
polyubiquitin
chain
depth
discuss
dub
mechanismofact
refer
reader
sever
excel
review
subject
given
promin
role
play
ubiquityl
process
ddr
surpris
find
multipl
dub
involv
regul
dna
repair
downstream
process
fig
signific
interest
ubiquitin
protein
ddr
regul
potenti
drug
target
review
focu
dub
drug
target
class
feel
far
underappreci
underexploit
survey
mani
dub
intim
connect
ddr
associ
cancerrelev
pathway
highlight
context
dub
inhibitor
may
offer
excit
new
opportun
treat
cancer
eventu
synthet
lethal
relat
strategi
protein
one
first
ubiquitin
hydrolas
characteris
key
player
welldefin
ddr
pathway
thu
shown
select
hydrolys
monoubiquitin
adduct
protein
pcna
monoubiquityl
fa
protein
critic
effect
icl
dna
repair
monoubiquityl
destabilis
protein
form
protein
equal
stabl
howev
monoubiquityl
approxim
gene
belong
dub
famili
peptidas
six
class
dub
identifi
far
human
genom
five
famili
belong
cystein
peptidas
class
ubiquitin
carboxyltermin
hydrolas
uch
ubiquitinspecif
proteas
usp
senp
sumo
peptidas
otu
mjd
addit
mpn
jamm
famili
belong
metallopeptidas
class
enzym
phylogenet
tree
repres
human
dub
cover
bacteri
viral
dub
display
addit
level
diverg
regul
cell
cycledepend
manner
upon
monoubiquityl
lysin
relocalis
nuclear
dnadamag
foci
interact
recombinas
colocalis
interestingli
identifi
screen
enzym
prevent
remov
ubiquitin
like
monoubiquityl
level
regul
cell
cycl
also
shown
interact
directli
colocalis
chromatin
notabl
howev
isol
protein
display
strong
deubiquityl
activ
vitro
instead
cofactor
necessari
form
activ
enzym
repeatcontain
protein
form
stoichiometr
complex
cell
activ
catalyt
activ
complex
mechanist
increas
catalyt
turnov
k
cat
increas
affin
substrat
k
regul
dub
cofactor
upon
substrat
bind
common
regulatori
featur
class
peptidas
addit
also
shown
remov
monoubiquitin
pcna
thu
regul
one
earliest
step
transles
dna
synthesi
tl
process
specialis
dna
polymeras
synthesis
dna
past
dna
lesion
complex
also
recruit
monoubiquityl
pcna
via
interact
protein
protein
involv
replic
complex
load
pcna
onto
dna
effici
replic
independ
identifi
factor
requir
suppress
genom
instabl
initi
observ
indic
reduc
level
would
protect
cell
dna
damag
howev
followup
studi
evalu
role
gene
inactiv
studi
mice
clearli
demonstr
deplet
result
genom
instabl
target
delet
mous
result
elev
perinat
lethal
male
infertil
dna
crosslink
hypersensit
fa
phenotyp
mous
embryon
fibroblast
display
heighten
level
monoubiquityl
chromatin
exhibit
impair
focu
assembl
defect
hr
repair
interestingli
doubl
knockout
mice
display
higher
level
ddr
dysfunct
singl
knockout
condit
suggest
addit
ddr
role
beyond
effect
addit
support
critic
role
play
protect
cell
dna
damag
obtain
studi
chicken
cell
disrupt
result
cellular
hypersensit
dna
damag
agent
strongli
support
model
wherebi
posit
regul
dna
repair
disrupt
complex
cell
also
lead
increas
sensit
camptothecin
cpt
topoisomeras
inhibitor
poli
adpribos
polymeras
inhibitor
dna
crosslink
agent
mitomycin
c
mmc
togeth
defect
hr
defect
larg
rescu
remov
key
regul
dsb
repair
nhej
complex
thu
critic
regul
icl
repair
hr
togeth
fa
pathway
gener
role
suppress
nhej
replic
fork
stall
checkpoint
respons
control
phosphoryl
recent
evid
suggest
control
feedback
loop
limit
activ
rescu
dnadamag
cell
stimul
degrad
monoubiquityl
may
thu
repres
feedback
mechan
contribut
recoveri
damag
cell
addit
requir
prevent
aberr
recruit
dna
polymeras
j
replic
fork
lack
recruit
polymeras
j
replic
fork
result
decreas
replic
fork
speed
enhanc
genom
instabl
process
driven
gener
result
elev
pcna
ubiquityl
pcna
monoubiquityl
transles
synthesi
tl
polymeras
recruit
uv
lesion
also
recent
implic
ner
dna
repair
mechan
take
place
outsid
replic
phase
level
control
protein
level
apcc
low
level
enabl
robust
uvinduc
pcna
monoubiquityl
like
allow
recruit
tl
polymeras
uv
lesion
novel
function
deubiquityl
activ
recent
uncov
regul
stabil
id
inhibitor
dna
bind
protein
id
protein
antagonis
basichelixloophelix
bhlh
transcript
factor
inhibit
differenti
maintain
stem
cell
fate
id
ubiquityl
proteasom
degrad
occur
differenti
tissu
id
appear
escap
degrad
mani
neoplasm
whether
regul
id
protein
link
known
function
regul
dna
damag
respons
remain
fulli
determin
studi
author
abl
demonstr
catalyt
dub
activ
promot
vitro
transform
vivo
tumour
format
thu
support
model
act
oncogen
taken
togeth
key
role
promot
dna
repair
find
highlight
potenti
attract
target
develop
anticanc
drug
dub
oncogen
properti
regul
cellular
level
fatti
acid
synthas
fa
prostat
cell
furthermor
overexpress
confer
resist
apoptosi
induc
chemotherapeut
agent
cisplatin
paclitaxel
prostat
epitheli
cell
virtu
activ
deubiquityl
ligas
demonstr
regul
checkpoint
pathway
howev
unlik
abl
target
see
show
exquisit
select
toward
unfortun
role
play
regul
activ
dna
damag
condit
describ
remain
characteris
protein
mdmx
also
substrat
partner
one
two
isoform
human
cell
catalyt
activ
requir
mdmx
deubiquityl
accord
find
deplet
caus
destabilis
mdmx
result
decreas
cellular
mdmx
level
chemotherapeut
agent
cisplatin
regul
mdmx
level
moreov
deplet
sensitis
testicular
carcinoma
cell
cisplatin
suggest
pharmacolog
inhibit
may
lead
antitumour
activ
chromatinassoci
dub
regul
ubiquityl
histon
cellular
ablat
lead
checkpoint
activ
delay
sphase
progress
associ
accumul
dna
break
enhanc
replic
stress
virtu
abil
oppos
histon
ubiquityl
fact
overexpress
block
accumul
ubiquitin
ligas
dsb
site
link
key
pathway
assembl
repair
signal
compon
dsb
site
given
critic
select
role
play
replic
stress
tumour
surviv
one
might
specul
pharmacolog
inhibit
might
benefit
cancer
treatment
interestingli
ablat
also
describ
requir
hepatocytegrowth
factor
scatter
epitheli
cell
recent
describ
key
regul
stabil
interact
directli
deubiquityl
mule
result
reduc
level
defici
mice
viabl
development
normal
show
enhanc
apoptosi
spleen
thymu
upon
ionis
radiat
defici
mous
embryon
fibroblast
recapitul
phenotyp
one
would
expect
dub
regul
level
retard
growth
prematur
cellular
senesc
resist
oncogen
transform
hyperact
dna
damag
checkpoint
inde
suggest
potenti
oncogen
inhibit
activ
apoptosi
cellcycl
checkpoint
deplet
promot
cell
senesc
loss
inhibit
oncogeneinduc
primari
cell
transform
final
overexpress
subset
human
cancer
studi
recent
describ
role
modul
therapeut
efficaci
topoisomeras
ii
inhibitor
doxorubicin
ubiquityl
may
link
put
oncogen
statu
role
chemoresist
notabl
studi
also
indic
function
regul
growth
factor
signal
tolllik
pathway
tgfb
receptor
type
tnfa
receptor
growth
factoractiv
kinas
regul
wnt
signal
make
prime
target
evalu
oncolog
drug
target
strong
potenti
ddr
context
deplet
report
caus
accumul
nuclear
increas
transcript
activ
activ
account
abil
suppress
inhibit
proteasom
degrad
without
affect
degrad
differenti
effect
deplet
protein
stabil
may
due
differ
sensit
inhibit
proteasom
activ
freeunanchor
polyubiquitin
accumul
loss
indirectli
link
key
dna
damag
checkpoint
factor
strictli
identifi
modul
ddr
investig
need
assess
role
dna
damag
signal
repair
unstress
cell
level
kept
low
via
proteasom
target
stress
condit
stabilis
contribut
ddr
initi
name
hausp
pivot
role
regul
checkpoint
upon
dna
damag
furthermor
specif
isoform
recent
describ
downstream
effector
checkpoint
pathway
control
dsbrespons
kinas
atm
activ
downregul
atmdepend
protein
phosphatas
respons
dna
damag
therebi
impair
activ
respons
member
forkhead
box
transcript
factor
regul
cellular
metabol
cellcycl
progress
cell
death
regul
monoubiquityl
respons
oxid
stress
result
relocalis
nucleu
increas
transcript
activ
notabl
identifi
dub
deubiquityl
modul
transcript
activ
respons
oxid
stress
make
prime
control
oxid
stress
respons
frequent
hallmark
tumour
often
associ
ddr
defect
also
report
modul
ber
oxid
lesion
modul
dna
access
consequ
rate
repair
oxid
lesion
effect
chromatin
remodel
transcriptioncoupl
nucleotid
excis
repair
tcner
subpathway
ner
effici
remov
highli
toxic
rna
polymeras
ii
block
lesion
dna
defect
tcner
give
rise
human
disorderscockayn
syndrom
uvsensit
syndrom
uvss
recent
uvssa
protein
shown
recruit
tcner
complex
upon
dna
damag
repres
critic
regulatori
mechan
restor
gene
express
upon
damag
describ
later
section
effort
target
small
molecul
inhibitor
undertaken
base
fact
regul
checkpoint
activ
also
behav
key
dub
multipl
ddr
pathway
myeloid
cell
leukaemia
sequenc
antiapoptot
member
famili
often
overexpress
tumour
cell
demonstr
factor
limit
therapeut
success
differ
member
highturnov
rate
express
tightli
regul
ubiquityl
dub
recent
deubiquitylas
ubiquitinspecif
proteas
describ
factor
remov
polyubiquitin
chain
therebi
stabilis
increas
resist
apoptosi
induc
inhibitor
notabl
increas
protein
express
correl
prognosi
patient
multipl
myeloma
addit
ionis
radiationinduc
activ
inhibit
degrad
result
increas
radioresist
apoptosi
exact
linkag
stabil
radioresist
remain
firmli
demonstr
find
suggest
inhibit
might
use
conjunct
radiotherapi
cancer
treatment
demonstr
would
greater
effect
cancer
cell
normal
tissu
tempt
specul
cancer
low
level
express
aggress
pancreat
cancer
might
specif
sensitis
convent
therapeut
agent
tumour
suppressor
function
critic
regul
via
modul
stabil
sever
dub
implic
control
cytoplasm
ubiquitinspecif
proteas
deubiquityl
revers
nuclear
export
degrad
dna
damag
stabilis
fraction
transloc
nucleu
activ
transloc
stabilis
regul
atmmedi
phosphoryl
addit
suppress
tumour
cell
growth
cell
wildtyp
express
downregul
high
percentag
clear
cell
carcinoma
known
mutat
recent
studi
also
suggest
regul
addit
modeofact
involv
tumour
suppressor
beclin
regul
activ
thu
impact
stabil
recent
identif
inhibitor
may
help
better
understand
ddr
role
way
identifi
therapeut
opportun
ubiquityl
chromosomeassoci
protein
import
mani
aspect
dna
repair
transcript
regul
import
facet
transcript
repress
polycomb
repress
complex
monoubiquityl
histon
combin
action
polycomb
group
protein
pcg
togeth
recruit
chromatin
site
bind
pcg
contribut
regul
tumour
suppressor
gene
locu
modul
ubiquityl
statu
pcg
protein
given
import
locu
oncogeneinduc
mechan
role
play
could
quit
critic
inde
central
function
ubiquityl
regul
possibl
promot
bypass
oncogeneinduc
senesc
stabilis
complex
suggest
excit
opportun
use
specif
usp
inhibitor
varieti
therapeut
context
includ
ddr
defici
background
accord
also
identifi
screen
factor
trigger
hypersensit
parp
inhibitor
catalyt
activ
need
effect
hr
repair
dsb
site
regard
mammalian
cell
lack
function
hypersensit
dna
damag
agent
show
genom
instabl
defici
homologydirect
dna
repair
sever
line
evid
point
toward
critic
role
regul
stabil
interact
copurifi
deubiquityl
deplet
sensitis
cell
dna
damag
agent
final
mitomycin
c
mmc
regul
stabil
manner
collect
clearli
link
essenti
ddr
mechan
oncogeneinduc
senesc
highlight
potenti
attract
target
therapeut
agent
similar
manner
characteris
enzym
remov
ubiquitin
histon
involv
regul
pathway
avail
evid
suggest
may
regul
dsbinduc
transcript
silenc
oppos
activ
recent
identif
histon
ubiquityl
target
add
addit
potenti
substrat
characteris
potenti
role
ddr
howev
still
infanc
investig
need
shed
light
cellular
role
damagespecif
dnabind
protein
first
isol
subunit
uvddb
heterodimer
complex
involv
dna
damag
recognit
ner
pathway
requir
effici
repair
uv
lesion
chromatin
compon
ligas
target
ubiquityl
histon
xpc
protein
function
damag
detect
involv
first
step
global
genom
ner
recent
identifi
dub
interact
involv
control
stabil
investig
precis
role
play
potenti
dub
ner
therefor
warrant
explor
respons
dna
damag
effector
kinas
atm
atr
dnapk
initi
cascad
cellular
effect
modul
gene
transcript
cellcycl
progress
dna
repair
apoptosi
factor
claspin
import
link
initi
respons
downstream
effector
ddr
pathway
identifi
interact
partner
loss
report
lead
irinduc
apoptosi
cell
similar
manner
seen
puma
null
mice
moreov
catalyt
activ
describ
essenti
function
independ
report
modul
activ
myc
protooncogen
author
claim
control
myc
stabil
antagonis
activ
scf
ubiquitin
ligas
complex
stabilis
myc
requir
prolifer
sever
tumour
cell
type
inhibit
cell
differenti
colon
carcinoma
number
report
suggest
steadyst
level
myc
rapidli
declin
respons
dna
damag
popov
et
al
suggest
dissoci
respons
dna
damag
provid
potenti
mechan
coupl
myc
stabil
dna
damag
firmli
connect
ddr
studi
remain
determin
extent
function
oper
cell
line
therefor
whether
repres
attract
therapeut
target
cellular
network
involv
cmyc
control
prolifer
differenti
apoptosi
respons
crossregul
varieti
stress
metabol
biosynthet
process
cmyc
gene
far
upstream
element
bind
protein
fbp
fbpinteract
repressor
fir
program
transcript
loop
rna
polymeras
ii
complex
engag
promot
anoth
fbp
partner
structur
subunit
multiaminoacyltrna
synthetas
ar
complex
also
report
stabilis
via
appar
independ
mechan
respons
oxid
stress
dissoci
ar
complex
transloc
nucleu
associ
fbp
coactiv
transcript
fbp
target
ubiquitinspecif
peptidas
previous
uncharacteris
deubiquityl
enzym
bind
cleav
polyubiquitin
chain
stabilis
accumul
quickli
induc
apoptosi
thu
fbp
help
coordin
molecular
cellular
respons
oxid
stress
mediat
preserv
genom
integr
cell
must
ensur
accur
time
segreg
chromosom
daughter
cell
mitosi
complex
pathway
known
spindl
assembl
checkpoint
mitot
checkpoint
ensur
transit
anaphas
delay
chromosom
kinetochor
properli
attach
mitot
spindl
directli
involv
ddr
defect
mitot
checkpoint
result
missegreg
chromosom
therebi
lead
genom
instabl
identifi
dub
critic
spindl
assembl
checkpoint
activ
rnai
screen
deplet
found
caus
bypass
checkpoint
recent
null
mice
gener
display
cellular
biochem
featur
consist
role
mitot
checkpoint
also
unravel
function
centrosom
regul
addit
defici
mice
found
prone
spontan
tumour
lung
support
role
tumour
suppressor
gene
underscor
role
cancer
ber
essenti
cellular
mechan
maintain
genom
stabil
mediat
repair
dna
lesion
aris
due
chemic
instabl
dna
molecul
base
chang
induc
endogen
environment
mutagen
polymeras
b
polb
critic
ber
enzym
possess
abas
site
lyas
activ
remov
sugar
phosphat
also
function
dna
polymeras
ad
one
nucleotid
end
aris
singlenucleotid
gap
identifi
major
enzym
deubiquityl
polb
mainli
stabilis
newli
synthesis
polb
consequ
regul
ber
activ
reduc
level
cytoplasm
polb
follow
deplet
unabl
effect
respond
dna
damag
induc
exogen
agent
mm
insuffici
elev
level
nuclear
polb
protein
requir
effici
dna
repair
also
describ
interact
partner
ubiquitin
ligas
complex
btrcp
author
studi
show
silenc
express
inhibit
cell
surviv
sensitis
cell
chemotherapeut
agentinduc
apoptosi
hypomorph
mous
model
gener
fibroblast
deriv
defici
mice
exhibit
uv
hypersensit
thu
support
role
ddr
along
thu
far
one
dub
describ
regul
ber
ubiquitin
ctermin
hydrolas
member
uch
class
dub
probabl
studi
dub
associ
neurodegen
condit
includ
parkinson
diseas
wide
rang
malign
gener
abund
literatur
despit
mani
aspect
molecular
mechan
function
remain
either
contradictori
poorli
understood
normal
almost
exclus
express
neuron
neuroendocrin
system
gonad
aberr
express
describ
mani
tumour
type
review
clear
role
ddr
formal
demonstr
includ
list
dub
report
modul
ubiquityl
statu
protein
checkpoint
pathway
thu
breast
cancer
model
induc
level
reduc
protein
level
also
induc
cellcycl
arrest
apoptosi
breast
tumour
cell
activ
requir
catalyt
activ
depend
accumul
similar
observ
also
made
head
neck
cancer
well
prostat
cancer
mention
public
support
role
tumour
suppressor
gene
although
also
import
mention
sever
report
demonstr
oncogen
properti
cancer
type
lymphoma
colorect
cancer
therefor
seem
play
import
role
tumorigenesi
clear
understand
mechan
ddr
role
remain
firmli
establish
also
quit
difficult
reconcil
role
play
neuron
neuroendocrin
cell
function
cancer
cell
belong
jamm
metalloenzym
famili
dub
lysin
specif
dub
member
two
protein
complex
dna
damagerespons
complex
cytoplasm
isopeptidas
complex
brisc
initi
isol
multiprotein
complex
contain
hrpromot
factor
notabl
deplet
shown
impair
activ
sensitis
breast
cancer
cell
irinduc
apoptosi
interact
brct
domain
ubiquitinbind
protein
target
complex
contain
ring
domain
protein
ligas
lysin
lysin
link
ubiquitin
polym
site
dsb
interestingli
appear
concomit
oppos
ubiquitin
ligas
ubiquitin
hydrolysi
activ
respons
determin
steadyst
ubiquitin
level
dsb
site
recent
discoveri
shed
light
modeofact
complex
thu
strike
contrast
complex
known
promot
homologydirect
repair
complex
restrict
dna
end
resect
phase
cell
cycl
therebi
limit
hr
consequ
defici
found
result
elev
dna
end
resect
concomit
increas
hr
mechan
reli
singlestrand
overhang
way
complex
limit
nucleas
activ
dsb
site
prevent
excess
end
resect
potenti
deleteri
homologydirect
dsb
repair
mechan
impair
genom
integr
notabl
human
gene
locat
locu
chromosom
breakpoint
patient
prolymphocyt
cell
leukaemia
furthermor
aberrantli
express
major
breast
tumour
indic
potenti
role
pathogenesi
diseas
take
find
togeth
clearli
key
player
control
cellular
dsb
respons
regul
ubiquityl
statu
repair
factor
dna
damag
site
member
mpn
jamm
famili
dub
initi
identifi
histon
deubiquityl
enzym
involv
regul
transcript
programm
epigenet
regul
b
cell
differenti
furthermor
analys
defici
mice
uncov
role
bone
marrow
stem
cell
mainten
control
oxid
stress
genom
stabil
hematopoiet
progenitor
develop
lymphoid
erythroid
lineag
given
intric
link
epigenet
regul
histon
ubiquityl
dna
damag
respons
interest
explor
role
play
process
sequenti
recruit
multipl
protein
complex
site
damag
involv
multipl
posttransl
modif
sever
key
step
requir
modif
ddr
protein
ubiquitin
ubiquitinlik
protein
sumo
atmdepend
phosphoryl
signal
lead
ubiquitin
conjug
dsb
site
promot
result
ubiquitinconjug
histon
protein
promot
recruit
protein
potenti
repair
dsb
signal
recent
proteasomeassoci
dub
shown
function
ddr
least
part
oppos
format
link
ubiquitin
chain
dsb
site
therebi
restrict
accumul
addit
author
found
also
enhanc
load
dna
damag
site
therebi
facilit
hr
repair
intriguingli
see
section
two
member
jamm
famili
chain
linkag
specif
known
affect
format
foci
codeplet
experi
suggest
act
repair
pathway
addit
connect
dsb
respons
proteasom
establish
recent
studi
sumotarget
ubiquitin
ligas
togeth
mediat
proteasom
recruit
dna
damag
site
promot
dsb
repair
otufamili
dub
identifi
neg
regul
ubiquityl
inhibit
dsbinduc
chromatin
ubiquityl
surprisingli
function
found
independ
isopeptidas
activ
instead
abl
bind
inhibit
subset
conjug
enzym
compris
protein
employ
notabl
use
highli
unusu
mechan
bind
inhibit
ubiquitincharg
assembl
pseudocleavag
product
catalyt
site
also
describ
regul
ubiquityl
cell
vitro
inhibit
markedli
impair
activ
induc
dna
damag
agent
etoposid
uv
light
appear
directli
suppress
ubiquityl
independ
catalyt
activ
suppress
activ
protein
function
interestingli
unlik
regul
ubiquityl
nucleu
cytoplasm
upon
dna
damag
similar
manner
see
role
regul
ddr
strongli
support
multipl
public
make
attract
therapeut
target
seem
clear
catalyt
activ
requir
process
thu
prevent
possibl
appli
classic
enzym
assaybas
drug
discoveri
inhibit
apart
role
metabol
energi
homeostasi
protein
shown
regul
ddr
deacetyl
protein
substrat
establish
role
ddr
protein
includ
foxo
factor
deacetyl
reduc
transcript
apoptot
activ
shown
sumoyl
desumoyl
regul
cellular
respons
genotox
stress
multipl
senp
play
critic
role
modul
prematur
senesc
suggest
inhibit
senp
may
attract
antitumour
activ
addit
level
correl
level
human
prostat
carcinoma
express
correl
sever
diseas
high
level
observ
aggress
prostat
cancer
also
report
critic
regul
activ
essenti
downstream
effector
atmdepend
ddr
howev
detail
mechanismofact
regul
ddr
still
clearli
establish
multipl
line
evid
link
desumoyl
enzym
regul
variou
aspect
ddr
exampl
respons
dna
damag
sumoyl
nemo
essenti
nfjb
modul
critic
nfjb
activ
notabl
effici
associ
nemo
desumoyl
nemo
inhibit
nfjb
activ
induc
dna
damag
interestingli
also
nfjb
induc
gene
nfjbdepend
induct
prevent
second
phase
nfjb
activ
significantli
limit
cell
surviv
respons
genotox
stress
anoth
ddr
link
come
desumoyl
protein
hnrnp
k
dnadamag
condit
hnrnpk
transient
stabilis
serv
transcript
coactiv
cellcycl
arrest
uvinduc
sumoyl
hnrnpk
shown
prevent
ubiquityl
stabilis
find
indic
sumo
modif
play
crucial
role
control
hnrnpk
function
coactiv
respons
dna
damag
revers
modif
like
also
affect
cellular
respons
uv
perhap
dna
damag
agent
regul
also
report
critic
promot
genom
integr
via
stress
respons
isoform
associ
regul
cellular
localis
ddr
function
replic
protein
complex
rpa
play
crucial
role
dna
replic
variou
ddr
process
notabl
kda
subunit
rpa
associ
nucleu
sumospecif
proteas
maintain
hyposumoyl
state
phase
cpt
induc
replic
stress
dissoci
allow
modifi
turn
facilit
recruit
dna
damag
site
promot
dna
repair
hr
result
thu
support
key
role
regul
hr
anoth
connect
ddr
come
histon
acetyltransferas
regul
ddr
acetyl
histon
remodel
chromatin
well
target
activ
ddr
kinas
atm
use
proteom
approach
identifi
bind
partner
interestingli
associ
two
protein
report
induc
uv
revers
modif
sumoyl
critic
impact
acetyltransferas
activ
illustr
ubiquitinlik
modif
abl
act
essenti
regul
ddr
pathway
ubiquitin
ubiquitinlik
system
exist
hijack
pathogen
virus
bacteria
interfer
proper
function
human
cell
sever
viral
dub
link
ddr
instanc
addit
cellular
dub
epsteinbarr
viru
dublik
protein
recent
describ
deubiquityl
pcna
attenu
polymeras
g
recruit
dna
damag
site
interestingli
dub
activ
conserv
amongst
member
herp
viru
famili
inhibit
proteasom
select
enzym
provid
excit
new
therapeut
opportun
mani
dub
describ
attract
therapeut
target
level
biolog
target
valid
becom
clear
mani
dub
inde
ddr
pathway
alreadi
alloc
least
one
dub
clearli
highlight
larg
number
ubiquitin
modif
involv
respons
dna
damag
also
interest
note
dub
famili
dub
report
play
critic
role
ddr
fig
dub
regul
process
hr
nhej
ner
ber
tl
fa
mismatch
repair
checkpoint
control
identifi
tabl
moreov
exampl
synthet
lethal
interact
ddr
pathway
clearli
identifi
mutat
tumour
fulli
function
normal
cell
trigger
plethora
screen
approach
identif
novel
therapeut
opportun
may
includ
dub
addit
mani
dub
link
cancer
pathway
link
ddr
pathway
thu
broaden
scope
dub
inhibitor
oncolog
said
drug
discoveri
aspect
dub
biolog
remain
larg
untap
challeng
select
inhibitor
dub
describ
far
nonetheless
limit
number
studi
report
summaris
select
cell
activ
inhibitor
deubiquitylas
complex
seem
abl
revers
cisplatinresist
nonsmal
cell
lung
cancer
cell
vitro
howev
clear
recapitul
phenotyp
expect
biochem
genet
fig
dub
involv
ddr
pathway
pictur
emerg
fine
control
certain
dub
play
dna
repair
process
cell
identifi
dub
select
inhibit
certain
ddr
pathway
target
cancer
cell
studi
use
inhibitor
remain
demonstr
see
section
describ
previous
seem
play
critic
role
mani
dna
repair
event
well
regul
pathway
unsurprisingli
receiv
much
attent
possibl
drug
target
develop
antitumour
therapi
remain
dub
use
paradigm
tackl
dub
drug
discoveri
select
inhibitor
identifi
recent
like
help
characteris
potenti
inhibitor
preclin
set
howev
number
attract
chemic
seri
select
inhibit
still
remain
limit
innov
drug
discoveri
breakthrough
would
benefit
field
inde
novel
technolog
advanc
current
employ
tackl
problem
addit
number
dub
inhibitor
variou
degre
select
whose
link
ddr
yet
evalu
describ
probe
inhibitor
senp
also
describ
recent
describ
know
mani
dub
modul
connect
ddr
key
interact
partner
substrat
summaris
well
pathway
dub
describ
involv
addit
chemotherapeut
agent
known
sensitis
tumour
cell
deplet
overexpress
dub
along
key
refer
support
data
list
summari
dub
involv
ddr
cell
biochem
biophi
deserv
closer
attent
potenti
therapeut
target
given
grow
interest
enzym
class
academ
group
pharma
biotech
mission
therapeut
seem
like
next
year
wit
signific
advanc
appreci
therapeut
opportun
dub
well
develop
compound
begin
exploit
potenti
clinic
recent
illustr
ddr
inhibitor
